Literature DB >> 16499824

Placebo, chronic daily headache, and pain: ten points to ponder.

Alvin E Lake1.   

Abstract

Entities:  

Mesh：

Year:  2006        PMID： 16499824     DOI： 10.1007/s11916-006-0002-6

Source DB:  PubMed          Journal:  Curr Pain Headache Rep        ISSN： 1534-3081


× No keyword cloud information.
  15 in total

1.  A comparison of placebo effects in clinical analgesic trials versus studies of placebo analgesia.

Authors:  Lene Vase; Joseph L Riley; Donald D Price
Journal:  Pain       Date:  2002-10       Impact factor: 6.961

2.  A quantification of the placebo response in migraine prophylaxis.

Authors:  P-H M van der Kuy; J J H M Lohman
Journal:  Cephalalgia       Date:  2002-05       Impact factor: 6.292

Review 3.  Chronic daily headache in the absence of medication overuse: is daily or continuous pain more treatment-resistant than chronic daily headache with pain-free days?

Authors:  Alvin E Lake
Journal:  Curr Pain Headache Rep       Date:  2005-02

4.  Management of chronic tension-type headache with tricyclic antidepressant medication, stress management therapy, and their combination: a randomized controlled trial.

Authors:  K A Holroyd; F J O'Donnell; M Stensland; G L Lipchik; G E Cordingley; B W Carlson
Journal:  JAMA       Date:  2001-05-02       Impact factor: 56.272

Review 5.  Nonspecific medication side effects and the nocebo phenomenon.

Authors:  Arthur J Barsky; Ralph Saintfort; Malcolm P Rogers; Jonathan F Borus
Journal:  JAMA       Date:  2002-02-06       Impact factor: 56.272

6.  Botulinum toxin type A for the prophylactic treatment of chronic daily headache: a randomized, double-blind, placebo-controlled trial.

Authors:  Stephen D Silberstein; Stuart R Stark; Sylvia M Lucas; Suzanne N Christie; Ronald E Degryse; Catherine C Turkel
Journal:  Mayo Clin Proc       Date:  2005-09       Impact factor: 7.616

7.  The placebo effect in acute headache management: ketorolac, meperidine, and saline in the emergency department.

Authors:  R N Harden; R H Gracely; T Carter; G Warner
Journal:  Headache       Date:  1996-06       Impact factor: 5.887

8.  Chronic daily headache prophylaxis with tizanidine: a double-blind, placebo-controlled, multicenter outcome study.

Authors:  Joel R Saper; Alvin E Lake; Deborah T Cantrell; Paul K Winner; Jeffery R White
Journal:  Headache       Date:  2002-06       Impact factor: 5.887

9.  Acute migraine treatment with droperidol: A randomized, double-blind, placebo-controlled trial.

Authors:  S D Silberstein; W B Young; J E Mendizabal; J F Rothrock; A S Alam
Journal:  Neurology       Date:  2003-01-28       Impact factor: 9.910

10.  Randomised trial of oral morphine for chronic non-cancer pain.

Authors:  D E Moulin; A Iezzi; R Amireh; W K Sharpe; D Boyd; H Merskey
Journal:  Lancet       Date:  1996-01-20       Impact factor: 79.321
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.